TEVETEN Side Effects

4910509-X | Psoriasis, Rash
on Jan 23, 2006 Male patient from GERMANY , 56 years of age, was diagnosed with hypertension and was treated with Teveten (View Usage). Patient experienced the following unwanted or unexpected effects: psoriasis, rash (What is rash?). Teveten dosage: 600 Mg Qd Po. Patient was hospitalized.

4886618-0 | C-reactive Protein Increased, Hypotension, Syncope
Patient was taking Teveten (View Usage). Patient had the following side effects: c-reactive protein increased, hypotension, syncope on Jan 09, 2006 from GERMANY Additional patient health information: Male patient , 75 years of age, was diagnosed with hypertension and. Teveten dosage: 600 Mg Qd Po. During the same period patient was treated with HYTRIN (10 Mg Qd Po) (View Hytrin Review and Hytrin Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), GINKO EXTRACT (View Ginko Extract Review and Ginko Extract Label ). Patient was hospitalized.

4883117-7 | Hypotension, Syncope
Adverse event was reported on Dec 30, 2005 by a Male patient taking Teveten (View Usage) (Dosage: 600 Mg Qd Po) was diagnosed with hypertension and. Location: GERMANY , 75 years of age, After Teveten was administered, patient had the following side effects: hypotension, syncope. During the same period patient was treated with HYTRIN (10 Mg Qd Po) (View Hytrin Review and Hytrin Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), GINKGO EXTRACT (View Ginkgo Extract Review and Ginkgo Extract Label ). Patient was hospitalized.

4881860-7 | Bronchitis, Thrombocytopenia
on Jan 12, 2006 Male patient from UNITED STATES , 62 years of age, weighting 273.4 lb, was diagnosed with hypertension and was treated with Teveten (View Usage). Patient experienced the following unwanted or unexpected effects: bronchitis (What is bronchitis?), thrombocytopenia. Teveten dosage: . Patient was hospitalized.


4869036-0 | Asthma, Condition Aggravated, Left Ventricular Failure
on Dec 08, 2005 Male patient from GERMANY , 82 years of age, was diagnosed with hypertension and was treated with Teveten (View Usage). Patient had the following side effects: asthma (What is asthma?), condition aggravated, left ventricular failure. Teveten dosage: 400 Mg Qd Po. During the same period patient was treated with LOSARTAN (View Losartan Review and Losartan Label ), FRUSEMIDE (View Frusemide Review and Frusemide Label ), DILTIAZEM HCL (View Diltiazem Hcl Review and Diltiazem Hcl Label ), WARFARIN (View Warfarin Review and Warfarin Label ), BECLAMETHASONE (View Beclamethasone Review and Beclamethasone Label ), SALBUTAMOL (View Salbutamol Review and Salbutamol Label ), MONTELUKAST (View Montelukast Review and Montelukast Label ), PERINDOPRIL (View Perindopril Review and Perindopril Label ). Patient was hospitalized.

4869035-9 | Haematoma, Haematuria, Malaise, Multi-organ Failure, Night Sweats, Pneumonia
Patient was taking Teveten (View Usage). After Teveten was administered, patient had the following side effects: haematoma, haematuria, malaise, multi-organ failure, night sweats, pneumonia (What is pneumonia?) on Dec 12, 2005 from GERMANY Additional patient health information: Female patient , 88 years of age, was diagnosed with hypertension and. Teveten dosage: 600 Mg Qd Po. During the same period patient was treated with PLAVIX (View Plavix Review and Plavix Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), DILTIAZEM HCL (View Diltiazem Hcl Review and Diltiazem Hcl Label ), ZOLOFT (View Zoloft Review and Zoloft Label ), HYDROXOCOBALAMIN (View Hydroxocobalamin Review and Hydroxocobalamin Label ), FOSAMAX /ITA/ (View Fosamax /ita/ Review and Fosamax /ita/ Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), CALCIUM/VITAMIN D (View Calcium/vitamin D Review and Calcium/vitamin D Label ). Patient was hospitalized.

4867924-2 | Hypertension, Syncope
Adverse event was reported on Dec 15, 2005 by a Female patient taking Teveten (View Usage) (Dosage: 600 Mg Qhs Po) was diagnosed with hypertension and. Location: GERMANY , 84 years of age, Patient experienced the following unwanted or unexpected effects: hypertension, syncope. During the same period patient was treated with PERINDOPRIL (View Perindopril Review and Perindopril Label ), NIFURTOINOL (View Nifurtoinol Review and Nifurtoinol Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), FENOFIBRATE (View Fenofibrate Review and Fenofibrate Label ), BUFLOMEDIL (View Buflomedil Review and Buflomedil Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ), FLUTICASONE PROPIONATE SALMETEROL (View Fluticasone Propionate Salmeterol Review and Fluticasone Propionate Salmeterol Label ). Patient was hospitalized.

4864952-8 | Dementia, Dizziness, Hyponatraemia, Memory Impairment
on Nov 30, 2005 Female patient from UNITED STATES , 88 years of age, was treated with Teveten (View Usage). Patient had the following side effects: dementia (What is dementia?), dizziness (What is dizziness?), hyponatraemia, memory impairment. Teveten dosage: . During the same period patient was treated with TRIMETHOPRIM (View Trimethoprim Review and Trimethoprim Label ), NOZINAN (View Nozinan Review and Nozinan Label ). Patient was hospitalized.

4848061-X | Confusional State, Dizziness, Malaise, Somnolence
on Nov 24, 2005 Female patient from UNITED KINGDOM , 77 years of age, was diagnosed with hypertension and was treated with Teveten (View Usage). After Teveten was administered, patient had the following side effects: confusional state, dizziness (What is dizziness?), malaise, somnolence. Teveten dosage: 300 Mg Qd Po. During the same period patient was treated with BENDROFLUAZIDE (View Bendrofluazide Review and Bendrofluazide Label ), CINNARIZINE (View Cinnarizine Review and Cinnarizine Label ).

4842898-9 | Syncope
Patient was taking Teveten (View Usage). Patient experienced the following unwanted or unexpected effects: syncope on Nov 10, 2005 from BELGIUM Additional patient health information: Female patient , 84 years of age, was diagnosed with hypertension and. Teveten dosage: 600 Mg Qhs Po. During the same period patient was treated with PERINDOPRIL (View Perindopril Review and Perindopril Label ), NIFURTOINOL (View Nifurtoinol Review and Nifurtoinol Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), FENOFIBRATE (View Fenofibrate Review and Fenofibrate Label ), BUFLOMEDIL (View Buflomedil Review and Buflomedil Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ), FLUTICASONE PROPIONATE SALMETEROL (View Fluticasone Propionate Salmeterol Review and Fluticasone Propionate Salmeterol Label ). Patient was hospitalized.

4842895-3 | Blood Pressure Systolic Increased, Haematuria, Pneumonia
Adverse event was reported on Nov 11, 2005 by a Female patient taking Teveten (View Usage) (Dosage: 600 Mg Po) was diagnosed with hypertension and. Location: GERMANY , 88 years of age, Patient had the following side effects: blood pressure systolic increased, haematuria, pneumonia (What is pneumonia?). During the same period patient was treated with PLAVIX (View Plavix Review and Plavix Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), DILTIAZEM HCL (View Diltiazem Hcl Review and Diltiazem Hcl Label ), ZOLOFT /USA/ (View Zoloft /usa/ Review and Zoloft /usa/ Label ), HYDROXOCOBALAMIN (View Hydroxocobalamin Review and Hydroxocobalamin Label ), FOSAMAX /ITA/ (View Fosamax /ita/ Review and Fosamax /ita/ Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), CALCIUM/VITAMIN D (View Calcium/vitamin D Review and Calcium/vitamin D Label ). Patient was hospitalized.

4836633-8 | Bronchitis, Loss Of Consciousness, Nausea
on Nov 14, 2005 Female patient from UNITED STATES , 69 years of age, weighting 551.2 lb, was diagnosed with hypertension and was treated with Teveten (View Usage). After Teveten was administered, patient had the following side effects: bronchitis (What is bronchitis?), loss of consciousness, nausea (What is nausea?). Teveten dosage: 600 Mg Qd Po. During the same period patient was treated with AGGRENOX (View Aggrenox Review and Aggrenox Label ), LOPRESSOR (View Lopressor Review and Lopressor Label ), LASIX (View Lasix Review and Lasix Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), PAXIL (View Paxil Review and Paxil Label ), AVANDIA (View Avandia Review and Avandia Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ). Patient was hospitalized.

4835775-0 | Completed Suicide
on Nov 11, 2005 Male patient from GERMANY , 55 years of age, was diagnosed with hypertension and was treated with Teveten (View Usage). Patient experienced the following unwanted or unexpected effects: completed suicide. Teveten dosage: 600 Mg Qd Po. During the same period patient was treated with MIRTAZAPINE (View Mirtazapine Review and Mirtazapine Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ), OLANZAPINE (View Olanzapine Review and Olanzapine Label ).

4831081-9 | Myocardial Infarction
Patient was taking Teveten (View Usage). Patient had the following side effects: myocardial infarction on Nov 03, 2005 from GERMANY Additional patient health information: Female patient , 79 years of age, was diagnosed with hypertension and. Teveten dosage: 600 Mg Qd Po. During the same period patient was treated with FUROSEMIDE (View Furosemide Review and Furosemide Label ), PHENPROCOUMON (View Phenprocoumon Review and Phenprocoumon Label ), DIGITOXIN TAB (View Digitoxin Tab Review and Digitoxin Tab Label ).

4823436-3 | Condition Aggravated, Corneal Dystrophy, Pain In Extremity, Vision Blurred
Adverse event was reported on Oct 17, 2005 by a Female patient taking Teveten (View Usage) (Dosage: 600 Mg Qd Po) was diagnosed with hypertension and. Location: CANADA , 69 years of age, After Teveten was administered, patient had the following side effects: condition aggravated, corneal dystrophy, pain in extremity, vision blurred. During the same period patient was treated with NORVASC (View Norvasc Review and Norvasc Label ), ACEBUTOLOL HCL (View Acebutolol Hcl Review and Acebutolol Hcl Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), ZOCOR (View Zocor Review and Zocor Label ).

4822756-6 | Back Pain, Blood Pressure Systolic Increased, Renal Artery Stenosis
on Oct 20, 2005 Male patient from GERMANY , 53 years of age, was diagnosed with hypertension and was treated with Teveten (View Usage). Patient experienced the following unwanted or unexpected effects: back pain (What is back pain?), blood pressure systolic increased, renal artery stenosis. Teveten dosage: 600 Mg Qd Po.

4822753-0 | Atrioventricular Block Second Degree, Blood Pressure Diastolic Increased, Blood Pressure Systolic Increased, Dizziness, Fatigue
on Oct 20, 2005 Female patient from GERMANY , 73 years of age, was diagnosed with hypertension and was treated with Teveten (View Usage). Patient had the following side effects: atrioventricular block second degree, blood pressure diastolic increased, blood pressure systolic increased, dizziness (What is dizziness?), fatigue. Teveten dosage: 600 Mg Qd Po. During the same period patient was treated with ATENOLOL (View Atenolol Review and Atenolol Label ), OXAZEPAM (View Oxazepam Review and Oxazepam Label ), TRIAMTERENE (View Triamterene Review and Triamterene Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ).

4815506-0 | Blood Pressure Systolic Increased
Patient was taking Teveten (View Usage). After Teveten was administered, patient had the following side effects: blood pressure systolic increased on Oct 20, 2005 from NETHERLANDS Additional patient health information: Male patient , 87 years of age, was diagnosed with hypertension and. Teveten dosage: 600 Milligram (s) Oral. During the same period patient was treated with HCT (HYDROCHLOROTHIAZIDE) (View Hct (hydrochlorothiazide) Review and Hct (hydrochlorothiazide) Label ).

4815504-7 | Blood Pressure Increased, Pneumonia
Adverse event was reported on Oct 20, 2005 by a Female patient taking Teveten (View Usage) (Dosage: 600 Milligram(s), Oral) was diagnosed with hypertension and. Location: NETHERLANDS , 88 years of age, Patient experienced the following unwanted or unexpected effects: blood pressure increased, pneumonia (What is pneumonia?). During the same period patient was treated with PLAVIX (View Plavix Review and Plavix Label ), ACETOSAL (ACETYLSALICYLIC ACID) (View Acetosal (acetylsalicylic Acid) Review and Acetosal (acetylsalicylic Acid) Label ), DILTIAZEM HYDROCHLORIDE (View Diltiazem Hydrochloride Review and Diltiazem Hydrochloride Label ), ZOLOFT (View Zoloft Review and Zoloft Label ), HYDROCOBAMINE (HYDROXOCOBALAMIN HYDROCHLORIDE) (View Hydrocobamine (hydroxocobalamin Hydrochloride) Review and Hydrocobamine (hydroxocobalamin Hydrochloride) Label ).

4810014-5 | Blood Pressure Fluctuation, Blood Pressure Increased, Gouty Arthritis, Renal Artery Stenosis, Renal Failure
on Oct 12, 2005 Male patient from BELGIUM , 78 years of age, was diagnosed with hypertension and was treated with Teveten (View Usage). Patient had the following side effects: blood pressure fluctuation, blood pressure increased, gouty arthritis, renal artery stenosis, renal failure. Teveten dosage: 600 Mg Qd Po. During the same period patient was treated with NATRII VALPROAS (View Natrii Valproas Review and Natrii Valproas Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), SOTALOL (View Sotalol Review and Sotalol Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), ZOLPIDEM TARTRATE (View Zolpidem Tartrate Review and Zolpidem Tartrate Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), ESCITALOPRAM OXALATE (View Escitalopram Oxalate Review and Escitalopram Oxalate Label ). Patient was hospitalized.

4810013-3 | Bronchitis Acute, Hypertension
on Oct 12, 2005 Female patient from BELGIUM , 79 years of age, was diagnosed with hypertension, musculoskeletal pain and was treated with Teveten (View Usage). After Teveten was administered, patient had the following side effects: bronchitis acute, hypertension. Teveten dosage: 600 Mg Po. During the same period patient was treated with DICLOFENAC (View Diclofenac Review and Diclofenac Label ), LEVOTHYROXINE (View Levothyroxine Review and Levothyroxine Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), INDAPAMIDE (View Indapamide Review and Indapamide Label ). Patient was hospitalized.

4810011-X | Coronary Angioplasty
Patient was taking Teveten (View Usage). Patient experienced the following unwanted or unexpected effects: coronary angioplasty on Oct 11, 2005 from NETHERLANDS Additional patient health information: Male patient , 68 years of age, was diagnosed with hypertension and. Teveten dosage: 600 Mg Qd Po. During the same period patient was treated with ACETYLSALICYLATE CALCIUM (View Acetylsalicylate Calcium Review and Acetylsalicylate Calcium Label ), ISOSORBIDE MONONITRATE (View Isosorbide Mononitrate Review and Isosorbide Mononitrate Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ). Patient was hospitalized.

4810008-X | Blood Pressure Systolic Abnormal
Adverse event was reported on Oct 13, 2005 by a Female patient taking Teveten (View Usage) (Dosage: 600 Mg Po) was diagnosed with hypertension and. Location: NETHERLANDS , 75 years of age, Patient had the following side effects: blood pressure systolic abnormal. During the same period patient was treated with GLIMEPIRIDE (View Glimepiride Review and Glimepiride Label ), MIXTARD HUMAN 70/30 (View Mixtard Human 70/30 Review and Mixtard Human 70/30 Label ), GEMFIBROZIL (View Gemfibrozil Review and Gemfibrozil Label ).

4810004-2 | Lung Infection, Pulmonary Embolism
on Oct 10, 2005 Female patient from BELGIUM , 82 years of age, was diagnosed with hypertension and was treated with Teveten (View Usage). After Teveten was administered, patient had the following side effects: lung infection, pulmonary embolism (What is pulmonary embolism?). Teveten dosage: 600 Mg Daily Po. During the same period patient was treated with PIRACETAM (View Piracetam Review and Piracetam Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

4810003-0 | Endometrial Cancer, Neoplasm Recurrence
on Oct 06, 2005 Female patient from NETHERLANDS , 77 years of age, was diagnosed with hypertension and was treated with Teveten (View Usage). Patient experienced the following unwanted or unexpected effects: endometrial cancer, neoplasm recurrence. Teveten dosage: 600 Mg Po. During the same period patient was treated with FUROSEMIDE (View Furosemide Review and Furosemide Label ), ACETAZOLAMIDE (View Acetazolamide Review and Acetazolamide Label ).

4803695-3 | Ventricular Fibrillation
Patient was taking Teveten (View Usage). Patient had the following side effects: ventricular fibrillation on Sep 29, 2005 from NETHERLANDS Additional patient health information: Male patient , 64 years of age, was diagnosed with hypertension and. Teveten dosage: 600 Mg Po. During the same period patient was treated with LANOXIN (View Lanoxin Review and Lanoxin Label ), ACENOCOUMAROL (View Acenocoumarol Review and Acenocoumarol Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ).

4798357-5 | Ischaemic Stroke
Adverse event was reported on Sep 26, 2005 by a Female patient taking Teveten (View Usage) (Dosage: 600 Mg Qhs Po) was diagnosed with hypertension and. Location: MALTA , 77 years of age, After Teveten was administered, patient had the following side effects: ischaemic stroke. During the same period patient was treated with BENDROFLUAZIDE (View Bendrofluazide Review and Bendrofluazide Label ).

4795013-4 | No Adverse Effect
on Sep 27, 2005 Female patient from GERMANY , 69 years of age, was diagnosed with hypertension and was treated with Teveten (View Usage). Patient experienced the following unwanted or unexpected effects: no adverse effect. Teveten dosage: 600 Mg Qd Po. During the same period patient was treated with SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), HYPERICIN (View Hypericin Review and Hypericin Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ).

4795009-2 | Autonomic Nervous System Imbalance, Hypertension, Loss Of Consciousness, Orthostatic Hypotension
on Sep 20, 2005 Male patient from GERMANY , 76 years of age, was diagnosed with hypertension and was treated with Teveten (View Usage). Patient had the following side effects: autonomic nervous system imbalance, hypertension, loss of consciousness, orthostatic hypotension. Teveten dosage: 600 Mg Po. Patient was hospitalized.

4795007-9 | Cerebrovascular Accident
Patient was taking Teveten (View Usage). After Teveten was administered, patient had the following side effects: cerebrovascular accident on Sep 19, 2005 from NETHERLANDS Additional patient health information: Male patient , 73 years of age, was diagnosed with hypertension and. Teveten dosage: 600 Mg Qd Po. Patient was hospitalized.

4766374-7 | Volvulus Of Bowel
Adverse event was reported on Aug 25, 2005 by a Female patient taking Teveten (View Usage) (Dosage: 600 Mg Qd Po) was diagnosed with hypertension and. Location: NETHERLANDS , 62 years of age, Patient experienced the following unwanted or unexpected effects: volvulus of bowel. Patient was hospitalized.

4760287-2 | Cerebrovascular Accident, Loss Of Consciousness
on Aug 16, 2005 Male patient from AUSTRALIA , 54 years of age, was diagnosed with hypertension and was treated with Teveten (View Usage). Patient had the following side effects: cerebrovascular accident, loss of consciousness. Teveten dosage: 600 Mg Po. During the same period patient was treated with ALDOMET (View Aldomet Review and Aldomet Label ), PERINDOPRIL AND INDAPAMIDE (View Perindopril And Indapamide Review and Perindopril And Indapamide Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), GLIPIZIDE (View Glipizide Review and Glipizide Label ), NORVASC (View Norvasc Review and Norvasc Label ), LIPITOR (View Lipitor Review and Lipitor Label ).

4754877-0 | Diarrhoea, Fall, Fatigue, Intentional Misuse, Overdose, Suicide Attempt
on Aug 10, 2005 Female patient from GERMANY , 17 years of age, was treated with Teveten (View Usage). After Teveten was administered, patient had the following side effects: diarrhoea, fall (What is fall?), fatigue, intentional misuse, overdose, suicide attempt. Teveten dosage: 12000 Mg Po. Patient was hospitalized.

4752534-8 | Diarrhoea, Fall, Fatigue, Intentional Misuse, Overdose, Suicide Attempt
Patient was taking Teveten (View Usage). Patient experienced the following unwanted or unexpected effects: diarrhoea, fall (What is fall?), fatigue, intentional misuse, overdose, suicide attempt on Aug 08, 2005 from GERMANY Additional patient health information: Female patient , 17 years of age, . Teveten dosage: 12000 Mg Po. Patient was hospitalized.

4750367-X | Cerebrovascular Accident, Hypertension, Loss Of Consciousness
Adverse event was reported on Aug 08, 2005 by a Male patient taking Teveten (View Usage) (Dosage: ) was diagnosed with hypertension and. Location: AUSTRALIA , 54 years of age, Patient had the following side effects: cerebrovascular accident, hypertension, loss of consciousness. During the same period patient was treated with METHYLDOPA (View Methyldopa Review and Methyldopa Label ), COVERSYL PLUS (View Coversyl Plus Review and Coversyl Plus Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), GLIPIZDE (View Glipizde Review and Glipizde Label ), AMLODIPINE BESILATE (View Amlodipine Besilate Review and Amlodipine Besilate Label ), ATORVASTATIN (View Atorvastatin Review and Atorvastatin Label ).

4749059-2 | Bronchitis Acute, Hypertension, Hypotension
on Aug 02, 2005 Female patient from BELGIUM , 79 years of age, was diagnosed with hypertension, musculoskeletal pain and was treated with Teveten (View Usage). After Teveten was administered, patient had the following side effects: bronchitis acute, hypertension, hypotension. Teveten dosage: 600 Mg Po. During the same period patient was treated with DICLOFENAC (View Diclofenac Review and Diclofenac Label ), LEVOTHYROXINE (View Levothyroxine Review and Levothyroxine Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), INDAPAMIDE (View Indapamide Review and Indapamide Label ). Patient was hospitalized.

4746342-1 | Renal Failure Acute, Syncope
on Jul 29, 2005 Male patient from BELGIUM , 82 years of age, was diagnosed with hypertension and was treated with Teveten (View Usage). Patient experienced the following unwanted or unexpected effects: renal failure acute, syncope. Teveten dosage: 600 Mg Qd Po. During the same period patient was treated with CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ). Patient was hospitalized.

4741546-6 | Arthralgia, Dizziness, Headache, Joint Swelling, Lethargy
Patient was taking Teveten (View Usage). Patient had the following side effects: arthralgia, dizziness (What is dizziness?), headache (What is headache?), joint swelling, lethargy on Jul 11, 2005 from UNITED KINGDOM Additional patient health information: Female patient , 62 years of age, was diagnosed with hypertension and. Teveten dosage: 600 Mg Qd Po. During the same period patient was treated with LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ), CODEINE (View Codeine Review and Codeine Label ), ASPIRIN, CAFFEINE, PARACETAMOL (View Aspirin, Caffeine, Paracetamol Review and Aspirin, Caffeine, Paracetamol Label ), OXAZEPAM (View Oxazepam Review and Oxazepam Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ).

4733520-0 | Renal Failure Acute, Syncope
Adverse event was reported on Jul 18, 2005 by a Male patient taking Teveten (View Usage) (Dosage: 600 Mg Qd Po) was diagnosed with hypertension and. Location: BELGIUM , 82 years of age, After Teveten was administered, patient had the following side effects: renal failure acute, syncope. During the same period patient was treated with CLOPIDOGREL BISULFATE (View Clopidogrel Bisulfate Review and Clopidogrel Bisulfate Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ).

4727753-7 | Bronchitis Acute, Hypertension
on Jul 12, 2005 Female patient from BELGIUM , 79 years of age, was diagnosed with hypertension and was treated with Teveten (View Usage). Patient experienced the following unwanted or unexpected effects: bronchitis acute, hypertension. Teveten dosage: 600 Mg Po. During the same period patient was treated with LEVOTHYROXINE (View Levothyroxine Review and Levothyroxine Label ).

4727718-5 |
on Jul 14, 2005 Male patient from NETHERLANDS , 64 years of age, was diagnosed with hypertension and was treated with Teveten (View Usage). . Teveten dosage: 600 Mg Unk Po. During the same period patient was treated with LANOXIN (View Lanoxin Review and Lanoxin Label ), ACENOCOUMAROL (View Acenocoumarol Review and Acenocoumarol Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ).

4727716-1 | Cholelithiasis, Computerised Tomogram Abnormal, Gastritis Erosive, Hypertension, Pancreatic Cyst, Pancreatic Necrosis, Pancreatitis Relapsing
Patient was taking Teveten (View Usage). After Teveten was administered, patient had the following side effects: cholelithiasis, computerised tomogram abnormal, gastritis erosive, hypertension, pancreatic cyst, pancreatic necrosis, pancreatitis relapsing on Jul 13, 2005 from GERMANY Additional patient health information: Male patient , 65 years of age, was diagnosed with hypertension, thrombosis prophylaxis and. Teveten dosage: 600 Mg Unk Po. During the same period patient was treated with CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), MYCOPHENOLATE MOFETIL (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), TRIMETHOPRIM SULFAMETHOXAZOL (View Trimethoprim Sulfamethoxazol Review and Trimethoprim Sulfamethoxazol Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), CALCIUM ACETATE (View Calcium Acetate Review and Calcium Acetate Label ), COLECALCIFEROL (View Colecalciferol Review and Colecalciferol Label ), MAGNESIUM (View Magnesium Review and Magnesium Label ). Patient was hospitalized.

4716781-3 | Cardioversion
Adverse event was reported on Jul 05, 2005 by a Male patient taking Teveten (View Usage) (Dosage: 600 Mg Unk; Po) was diagnosed with hypertension, thrombosis prophylaxis and. Location: GERMANY , 64 years of age, Patient experienced the following unwanted or unexpected effects: cardioversion. During the same period patient was treated with LEVOXINE (View Levoxine Review and Levoxine Label ), ACENOCOUMAROL (View Acenocoumarol Review and Acenocoumarol Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ).

4716779-5 | Conduction Disorder, Disease Recurrence, Syncope
on Jun 29, 2005 Male patient from GERMANY , 53 years of age, was diagnosed with hypertension, thrombosis prophylaxis and was treated with Teveten (View Usage). Patient had the following side effects: conduction disorder, disease recurrence, syncope. Teveten dosage: 600 Mg Unk; Po. During the same period patient was treated with CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), MYOCOPHENOLATE MOFETIL (View Myocophenolate Mofetil Review and Myocophenolate Mofetil Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), CALCIUM GLUCONATE (View Calcium Gluconate Review and Calcium Gluconate Label ), VITAMIN D3 (View Vitamin D3 Review and Vitamin D3 Label ), MAGNESIUM HYDROGEN ASPARTATE (View Magnesium Hydrogen Aspartate Review and Magnesium Hydrogen Aspartate Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

4716776-X | Pericardial Effusion
on Jun 29, 2005 Male patient from GERMANY , 55 years of age, was diagnosed with hypertension, thrombosis prophylaxis and was treated with Teveten (View Usage). After Teveten was administered, patient had the following side effects: pericardial effusion. Teveten dosage: 600 Mg Unk; Po. During the same period patient was treated with CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), TRIMETHOPRIM (View Trimethoprim Review and Trimethoprim Label ), SULFAMETHOXAZOLE (View Sulfamethoxazole Review and Sulfamethoxazole Label ), CALCIUM GLUBIONATE (View Calcium Glubionate Review and Calcium Glubionate Label ). Patient was hospitalized.

4715658-7 | Inguinal Hernia
Patient was taking Teveten (View Usage). Patient experienced the following unwanted or unexpected effects: inguinal hernia on Jun 29, 2005 from GERMANY Additional patient health information: Male patient , 67 years of age, was diagnosed with hypertension, thrombosis prophylaxis and. Teveten dosage: 600 Mg Qd Po. During the same period patient was treated with CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), MYCOPHENOLATE MOFETIL (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), CALCIUM ACETATE (View Calcium Acetate Review and Calcium Acetate Label ), COLECALCIFEROL (View Colecalciferol Review and Colecalciferol Label ), MAGNESIUM (View Magnesium Review and Magnesium Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

4714517-3 | Cytomegalovirus Infection, Vertigo
Adverse event was reported on Jun 24, 2005 by a Male patient taking Teveten (View Usage) (Dosage: 600 Mg Qd Po) was diagnosed with hypertension and. Location: GERMANY , 68 years of age, Patient had the following side effects: cytomegalovirus infection (What is cytomegalovirus infection?), vertigo. During the same period patient was treated with DOXAZOSIN MESYLATE (8 Mg Unk Po) (View Doxazosin Mesylate Review and Doxazosin Mesylate Label ), CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), MYCOPHENOLATE MOFETIL (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), AMPHOTERICIN B (View Amphotericin B Review and Amphotericin B Label ), MAGNESIUM HYDROGEN ASPARTATE (View Magnesium Hydrogen Aspartate Review and Magnesium Hydrogen Aspartate Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), SULFAMETHOXAZOLE + TRIMETHOPRIM (View Sulfamethoxazole + Trimethoprim Review and Sulfamethoxazole + Trimethoprim Label ). Patient was hospitalized.

4713761-9 | Cholelithiasis, Gastritis Erosive, Pancreatic Cyst, Pancreatitis Relapsing
on Jun 29, 2005 Male patient from GERMANY , 65 years of age, was diagnosed with hypertension, thrombosis prophylaxis and was treated with Teveten (View Usage). After Teveten was administered, patient had the following side effects: cholelithiasis, gastritis erosive, pancreatic cyst, pancreatitis relapsing. Teveten dosage: 600 Mg Po. During the same period patient was treated with CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), MYCOPHENOLATE MOFETIL (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), TRIMETROPRIM SULFAMETHOXAZOL (View Trimetroprim Sulfamethoxazol Review and Trimetroprim Sulfamethoxazol Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), CALCIUM GLUCONATE (View Calcium Gluconate Review and Calcium Gluconate Label ), COLECALCIFEROL (View Colecalciferol Review and Colecalciferol Label ), MAGNESIUM (View Magnesium Review and Magnesium Label ). Patient was hospitalized.

4708798-X | Dizziness, Vision Blurred
on Jun 20, 2005 Female patient from CANADA , 81 years of age, was diagnosed with hypertension, oedema peripheral, atrial fibrillation (What is atrial fibrillation?) and was treated with Teveten (View Usage). Patient experienced the following unwanted or unexpected effects: dizziness (What is dizziness?), vision blurred. Teveten dosage: 600 Mg Po. During the same period patient was treated with LASIX (80 Mg Po) (View Lasix Review and Lasix Label ), DIGOXIN (0.125 Mg Po) (View Digoxin Review and Digoxin Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), PROPAFENONE (View Propafenone Review and Propafenone Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ). Patient was hospitalized.

4704632-2 | Herpes Zoster
Patient was taking Teveten (View Usage). Patient had the following side effects: herpes zoster on Jun 22, 2005 from Additional patient health information: Female patient , 69 years of age, was diagnosed with hypertension and. Teveten dosage: 600 Mg Qd Po. During the same period patient was treated with SIMVASTTIN (View Simvasttin Review and Simvasttin Label ), HYPERICIN (View Hypericin Review and Hypericin Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ).